Latest radiation therapy Stories
NEW YORK, Jan. 22, 2013 /PRNewswire/ -- Not all robots are created equal, particularly when it comes to prostate cancer, says world-renowned prostate cancer surgeon, Dr. David Samadi. Specializing in minimally invasive da Vinci robotic prostatectomy surgery, Dr. Samadi is not only Vice Chairman, Department of Urology at The Mount Sinai Medical Center; he is also Chief of Robotics and Minimally Invasive Surgery. (Photo: http://photos.prnewswire.com/prnh/20130122/NY45644 ) Robots...
Dr. Weiran Tang is the newly named Director of the Tumor Immunology Laboratory at Puhua International Hospitals-Temple of Heaven, Beijing, China. Beijing, China (PRWEB) (PRWEB) January 20, 2013 Puhua International Hospitals (PIH)-Temple of Heaven (http://www.puhuachina.com) has been a leading international hospital in Beijing, China, for the past 20 years. During that time PIH has maintained a dominant presence in Beijing, China in neurology, neurosurgery and related areas of medicine and...
Medical Center Adds Top of the Line Optima CT540 for Better Images and Lower Radiation JUPITER, Fla., Jan. 16, 2013 /PRNewswire-USNewswire/ -- Jupiter Medical Center (JMC) announced its installation of the Optima CT540 - THE FIRST IN THE COUNTRY. An advanced diagnostic computed tomography (CT) system from GE Healthcare, it offers improvements in image performance, workflow and lower dose imaging. (Photo: http://photos.prnewswire.com/prnh/20130116/DC43476) "Jupiter Medical Center...
NEW YORK, Jan. 11, 2013 /PRNewswire/ -- A comparative review of more than 230 previously published studies bumps radical prostate removal surgery above radiation in cost-effectiveness, quality of life after treatment, and patient survival. Surgery, whether performed traditionally, laparoscopically, or robotically, demonstrated improved outcomes across all three factors when compared to radiation for prostate cancer in the form of intensity-modulate radiation therapy, brachytherapy,...
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors. Reporting in the Jan. 9, 2013, edition of the on-line journal, PLOS ONE, the researchers describe a process of exploiting sickle-shaped red blood cells to selectively target oxygen deprived cancer tumors in mice and...
Sickle-shaped red blood cells target and destroy tumor cells and blood vessels The genetic mutation that causes sickle cell anemia also turns red blood cells into potent tumor killers and may offer a new way to treat some cancers that are resistant to existing treatments, according to research published January 9 in the open access journal PLOS ONE by David S. Terman of Jenomic Research Institute and colleagues from Duke University and other institutions. The mutation that causes sickle...
CARMEL, Calif., Jan. 9, 2013 /PRNewswire/ -- The genetic mutation that causes sickle cell anemia also turns red blood cells into potent tumor killers and may offer a new way to treat cancers that are resistant to existing treatments, according to research published January 9, 2013 in the open access journal PLOS ONE by David S. Terman of Jenomic Research Institute and colleagues from Duke University and other institutions. The mutation that causes sickle cell anemia to change the...
"Although mortality from many cancers has been steadily falling, particularly those of the blood [i.e., leukemias], the more important statistic may be that so many epithelial cancers (carcinomas) and effectively all mesenchymal cancers (sarcomas) remain largely incurable." With these words as preface, Nobel laureate James D. Watson, Ph.D., in a newly published paper that he regards "among my most important work since the double helix," sets forth a novel hypothesis regarding the role of...
JEDDAH, Saudi Arabia, Jan. 9, 2013 /PRNewswire/ -- In part to address the 12,000 new cancer cases annually in Saudi Arabia - many of them diagnosed at an advanced stage - King Abdulaziz University Hospital is the first center nationally to acquire image guided treatment technology from Elekta. The 700-bed hospital launched a new era of advanced radiotherapy with the first clinical treatments on its Elekta Synergy® system in February 2012, offering patients with difficult...
NEW YORK, Jan. 8, 2013 /PRNewswire/ -- Prostate cancer diagnoses may bring out the fight in men but patients need to know which punch to throw first. When diagnosed early, prostate cancer is highly treatable and patients most often choose between robotic prostate removal surgery or radiation for prostate cancer, including external beam radiation therapy (EBRT) and brachytherapy seed radiation. (Logo: http://photos.prnewswire.com/prnh/20130108/NY39190LOGO ) Three concerns drive...
